Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy. - Wikidata - wikimedia - TriplyDB

Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.

Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.

http://www.wikidata.org/entity/Q33403789

about

Study of Protein Biomarkers of Diabetes Mellitus Type 2 and Therapy with Vitamin B1 Applications of urinary proteomics in biomarker discovery Proteomics and systems biology for understanding diabetic nephropathy Circulating cellular adhesion molecules and risk of diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA).Diabetic nephropathy research in China: Data analysis and review from the National Natural Science Foundation of China.Urinary proteomics as a novel tool for biomarker discovery in kidney diseases.Adipocytokine zinc α2 glycoprotein (ZAG) as a novel urinary biomarker for normo-albuminuric diabetic nephropathy.Excretion of urinary orosomucoid 1 protein is elevated in patients with chronic heart failure.Soluble E-cadherin: more than a symptom of disease.L1 cell adhesion molecule expression is associated with pelvic lymph node metastasis and advanced stage in diabetic patients with endometrial cancer: a matched case control study Defining nephrotic syndrome from an integrative genomics perspective.Epithelial cells as active player in fibrosis: findings from an in vitro model.Novel 3D co-culture model for epithelial-stromal cells interaction in prostate cancer.Stage-specific quantitative changes in renal and urinary proteome during the progression and development of streptozotocin-induced diabetic nephropathy in rats.Effects of anesthetics pentobarbital sodium and chloral hydrate on urine proteome.Effects of three commonly-used diuretics on the urinary proteome.A tool for biomarker discovery in the urinary proteome: a manually curated human and animal urine protein biomarker database.Mass spectrometry for diabetic nephropathy monitoring: new effective tools for physicians.Exosomes and the kidney: prospects for diagnosis and therapy of renal diseases.Differential urinary glycoproteome analysis of type 2 diabetic nephropathy using 2D-LC-MS/MS and iTRAQ quantification.Elevated urinary level of vitamin D-binding protein as a novel biomarker for diabetic nephropathy.Proteomic approaches for discovering biomarkers of diabetic nephropathy.Proteome-base biomarkers in diabetes mellitus: progress on biofluids' protein profiling using mass spectrometry.Review and discussion of tubular biomarkers in the diagnosis and management of diabetic nephropathy.Recent technological developments in proteomics shed new light on translational research on diabetic microangiopathy.Body fluid peptide and protein signatures in diabetic kidney diseases.Urinary Proteomics for Diagnosis and Monitoring of Diabetic Nephropathy.E-cadherin gene 3'-UTR C/T polymorphism in Turkish patients with nephrolithiasis.MicroRNA, Proteins, and Metabolites as Novel Biomarkers for Prediabetes, Diabetes, and Related Complications.A Micro-Scale Model to Monitor the Major Proteins in Human Urine Before and After Medication with Angiotensin-Converting Enzyme Inhibitor: A Preliminary Study

P2860

Q26798146-51096D83-9073-48EF-9C12-21FDD6514796 Q27010368-1465BED8-5016-4E09-B537-DED034FD750C Q28728631-363FC312-C392-4F74-A9E0-27E461DA770B Q30277225-B7CFCDBE-D0CE-4038-9619-F3F62259232C Q30883079-2A0A13A8-E27E-4626-BF4C-812E80512C98 Q33781011-6A01D82C-C0EC-444F-B158-43859B5DC427 Q34115491-2469A2E5-7B44-4B4D-8C69-E992F639E083 Q34172662-DD574F69-C66D-4F6E-8EFA-D1366014E995 Q34279705-C6A138B5-E0DF-425A-8C1D-013AE3CA3535 Q34305634-D6E8704B-3DF6-411B-9A8B-75AEB0E2E074 Q34560989-C695739B-34C7-4546-A98C-4D17068DFCED Q34606895-F62C4D74-7B10-4F7F-ABF8-EF65F304B618 Q35000828-30C49181-B8B0-4DE9-84AE-5A9946AC4804 Q35054853-8881B33D-CB96-45E8-A70E-043F8CB8CF4C Q35184085-AD63BC41-B4D7-4CDD-90CA-96AEFB01D9EB Q35543587-2C9A301C-14DA-4C58-96A5-DD0BE1E67C50 Q35579632-FA28336B-1555-4301-A6B1-CDCB0EEF4A0C Q35997377-8246CCEE-28FF-4C77-8152-BA50ACC143B7 Q36141289-058C9CDE-5CD5-4BCE-AD07-A358E05A4416 Q36321624-DF5E4B9B-569F-4F3D-BB6C-536ADD01B060 Q37434486-0C98ED54-B229-401C-8B24-76581ECEFA82 Q37753489-215C5BEA-242C-430A-94CE-F5B62FCEA992 Q38045278-B4F379F5-25B9-47C9-815F-484828163389 Q38053941-3420B825-0E0F-4B5D-85D8-E6279AE5BAA1 Q38114159-A264A977-7B92-4F7A-831F-15FB38579364 Q38553924-199A29BF-5280-4EA5-ACEF-5B905710C1D5 Q38961899-F3CB8804-75C4-44FD-A640-8B070BB93120 Q54397109-B6A997B7-8CA8-4BA6-9E4A-B2C33974CFB1 Q54959769-DE2AD80F-6EDB-4BC4-8EC3-039CE8CF4316 Q58309332-E68E9676-049D-4E86-A4B0-3D973A9F222D

P2860

Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.

http://www.wikidata.org/entity/Q33403789

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Identification of urinary solu ...... rker for diabetic nephropathy.

@ast

Identification of urinary solu ...... rker for diabetic nephropathy.

@en

type

label

Identification of urinary solu ...... rker for diabetic nephropathy.

@ast

Identification of urinary solu ...... rker for diabetic nephropathy.

@en

prefLabel

Identification of urinary solu ...... rker for diabetic nephropathy.

@ast

Identification of urinary solu ...... rker for diabetic nephropathy.

@en

P1433

Q33403789-2DF4EEE7-1742-46F6-B8DF-3AF0FAB63C47

P1476

Q33403789-DAF84AAD-3CEA-48F5-AA83-CF6ABFCC7B46

P2093

Q33403789-0918CE94-5F41-4D32-8041-64DEE90FA46B

Q33403789-7E6002A3-C105-4FAC-96D0-7A174DCF7FF4

Q33403789-B7D874C0-83E8-4DCE-A5D0-0C734F476893

Q33403789-BA414EA5-F5F4-4DFF-ABD1-AB6677FB7756

Q33403789-C712F05D-1D31-4FC9-ADE5-02311B7EA613

Q33403789-F3F20829-624E-4EC4-AD0F-36252D94D8E0

P2860

Q33403789-0C7B8743-910C-40F6-B095-14A75C6A441A

Q33403789-20E5E4C1-4FEE-4CC8-888D-22EFA00B447E

Q33403789-A8B205E4-8561-49C6-B2D6-EE9922489CE0

P304

Q33403789-E56B6E9D-B802-4877-B152-2537C7F87220

P31

Q33403789-ADF8EF27-F3FC-4399-A261-2ABC0AA6FCC1

P356

Q33403789-318D3D3D-F8A6-486E-9C60-816ADB94825F

P433

Q33403789-F38D4FA8-8BBE-46B2-B980-6068D13D6EEC

P478

Q33403789-BED5B0A9-9639-4F49-B990-6036BD9A3BB4

P50

Q33403789-AB37A318-610D-4507-AE0F-39B6F3C93375

P577

Q33403789-57F30D43-0013-42D4-A22A-30B1C1227918

P698

Q33403789-EF3CEFF0-57C5-45F9-852B-31D9651D2933

P921

Q33403789-B409B8BB-8E79-47B5-B92E-9B6CD14D7E80

P356

P1433

Diabetes - Metabolism: Research and Reviews

P1476

Identification of urinary solu ...... rker for diabetic nephropathy.

@en

P2093

Gang Liu

http://www.w3.org/2001/XMLSchema#string

Guangju Guan

http://www.w3.org/2001/XMLSchema#string

Hongjuan Jiang

http://www.w3.org/2001/XMLSchema#string

Jing Cheng

http://www.w3.org/2001/XMLSchema#string

Rui Zhang

http://www.w3.org/2001/XMLSchema#string

Xianghua Hou

http://www.w3.org/2001/XMLSchema#string

P2860

Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway

Biogenesis of polarized epithelial cells during kidney development in situ: roles of E-cadherin-mediated cell-cell adhesion and membrane cytoskeleton organization

Retinol binding protein as a small molecular weight marker of renal tubular function in diabetes mellitus.

P304

232-241

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/DMRR.940

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19177462

http://www.w3.org/2001/XMLSchema#string

P921